| MYC, metabolism, and cancer ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang Cancer discovery 5 (10), 1024-1039, 2015 | 1244 | 2015 |
| Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis Y Xiang, ZE Stine, J Xia, Y Lu, RS O’Connor, BJ Altman, AL Hsieh, ... The Journal of clinical investigation 125 (6), 2293-2306, 2015 | 489 | 2015 |
| MYC and metabolism on the path to cancer AL Hsieh, ZE Walton, BJ Altman, ZE Stine, CV Dang Seminars in cell & developmental biology 43, 11-21, 2015 | 329 | 2015 |
| MYC disrupts the circadian clock and metabolism in cancer cells BJ Altman, AL Hsieh, A Sengupta, SY Krishnanaiah, ZE Stine, ZE Walton, ... Cell metabolism 22 (6), 1009-1019, 2015 | 292 | 2015 |
| The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth AM Gouw, K Margulis, NS Liu, SJ Raman, A Mancuso, GG Toal, L Tong, ... Cell metabolism 30 (3), 556-572. e5, 2019 | 165 | 2019 |
| MYC, metabolism, and cancer. Cancer Discov. 2015; 5: 1024–1039. doi: 10.1158/2159-8290 ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang CD-15-0507.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 149 | |
| MYC, metabolic synthetic lethality, and cancer AL Hsieh, CV Dang Metabolism in Cancer, 73-91, 2016 | 41 | 2016 |
| Comparison of type B dissection by open, endovascular, and medical treatments RW Hsieh, TC Hsu, M Lee, WT Hsu, ST Chen, AH Huang, AL Hsieh, ... Journal of vascular surgery 70 (6), 1792-1800. e3, 2019 | 30 | 2019 |
| MYC, metabolism, and cancer. Cancer Discov. 2015; 5 (10): 1024–1039. doi: 10.1158/2159-8290 ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang CD-15-0507.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 24 | |
| MYC, metabolism, and cancer. Cancer Discov. 5, 1024–1039. doi: 10.1158/2159-8290 ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang CD-15-0507, 2015 | 22 | 2015 |
| Deregulation of the cellular energetics of cancer cells ZE Stine, BJ Altman, AL Hsieh, AM Gouw, CV Dang Pathobiology of human disease: a dynamic encyclopedia of disease mechanisms …, 2014 | 21 | 2014 |
| Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα BJ Altman, AL Hsieh, AM Gouw, CV Dang Nature communications 8 (1), 14862, 2017 | 16 | 2017 |
| MYC, Metabolism, and Cancer. Cancer Discov. 2015; 5 (10): 1024–39. doi: 10.1158/2159-8290 ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang CD-15-0507, 2015 | 14 | 2015 |
| MYC, metabolism, and cancer. Cancer Discov. 2015; 5: 1024–39 ZE Stine, ZE Walton, BJ Altman, AL Hsieh, CV Dang | 14 | |
| MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis J Cazarin, RE DeRollo, SNABA Shahidan, JB Burchett, D Mwangi, ... PLoS genetics 19 (8), e1010904, 2023 | 8 | 2023 |
| Misregulation of Drosophila Myc disrupts circadian behavior and metabolism AL Hsieh, X Zheng, Z Yue, ZE Stine, A Mancuso, SD Rhoades, R Brooks, ... Cell reports 29 (7), 1778-1788. e4, 2019 | 7 | 2019 |
| Evolving concepts in meningioma management in the era of genomics AL Hsieh, WL Bi, V Ramesh, PK Brastianos, SR Plotkin Cancer, 2024 | 1 | 2024 |
| MYC regulation of metabolism and cancer AM Gouw, AL Hsieh, ZE Stine, CV Dang Tumor Cell Metabolism: Pathways, Regulation and Biology, 101-122, 2015 | 1 | 2015 |
| Rev-erbα modulates myc-driven cancer cell growth and altered metabolism BJ Altman, A Hsieh, AM Gouw, ZE Stine, A Venkataraman, DI Bellovin, ... Cancer Research 74 (19_Supplement), 2953-2953, 2014 | 1 | 2014 |
| A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design EA Wetzel, AI Nohman, AL Hsieh, D Reuss, AW Unterberg, IY Eyüpoglu, ... Journal of neuro-oncology, 1-9, 2024 | | 2024 |
Brian J. AltmanUniversity of RochesterVerified email at urmc.rochester.edu
